These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 31597207)

  • 21. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study.
    Brown J; Beard E; Kotz D; Michie S; West R
    Addiction; 2014 Sep; 109(9):1531-40. PubMed ID: 24846453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).
    Essex HN; Parrott S; Wu Q; Li J; Cooper S; Coleman T
    Nicotine Tob Res; 2015 Jun; 17(6):636-42. PubMed ID: 25481916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
    Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
    Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services.
    Gilbert H; Sutton S; Morris R; Petersen I; Wu Q; Parrott S; Galton S; Kale D; Magee MS; Gardner L; Nazareth I
    Health Technol Assess; 2017 Jan; 21(3):1-206. PubMed ID: 28121288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers.
    Taylor AH; Thompson TP; Greaves CJ; Taylor RS; Green C; Warren FC; Kandiyali R; Aveyard P; Ayres R; Byng R; Campbell JL; Ussher MH; Michie S; West R
    Health Technol Assess; 2014 Jan; 18(4):1-324. PubMed ID: 24433837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding decisions to use e-cigarettes or behavioural support to quit tobacco: a qualitative study of current and ex-smokers and stop smoking service staff.
    Hartwell G; Egan M; Petticrew M
    Addiction; 2020 Mar; 115(3):518-526. PubMed ID: 31628817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of population-level proactive tobacco cessation outreach among socio-economically disadvantaged smokers: evaluation of a randomized control trial.
    Thao V; Nyman JA; Nelson DB; Joseph AM; Clothier B; Hammett PJ; Fu SS
    Addiction; 2019 Dec; 114(12):2206-2216. PubMed ID: 31483549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
    Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are financial incentives cost-effective to support smoking cessation during pregnancy?
    Boyd KA; Briggs AH; Bauld L; Sinclair L; Tappin D
    Addiction; 2016 Feb; 111(2):360-70. PubMed ID: 26370095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.
    Daly AT; Deshmukh AA; Vidrine DJ; Prokhorov AV; Frank SG; Tahay PD; Houchen ME; Cantor SB
    Tob Control; 2019 Jan; 28(1):88-94. PubMed ID: 29886411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between electronic cigarette use and changes in quit attempts, success of quit attempts, use of smoking cessation pharmacotherapy, and use of stop smoking services in England: time series analysis of population trends.
    Beard E; West R; Michie S; Brown J
    BMJ; 2016 Sep; 354():i4645. PubMed ID: 27624188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD.
    Trapero-Bertran M; Muñoz C; Coyle K; Coyle D; Lester-George A; Leidl R; Németh B; Cheung KL; Pokhrel S; Lopez-Nicolás Á
    Addiction; 2018 Jun; 113 Suppl 1(Suppl Suppl 1):65-75. PubMed ID: 29532966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Cost-Effectiveness Analysis of Stop Smoking Interventions in Substance-Use Disorder Populations.
    Healey A; Roberts S; Sevdalis N; Goulding L; Wilson S; Shaw K; Jolley C; Robson D
    Nicotine Tob Res; 2019 Apr; 21(5):623-630. PubMed ID: 29733376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness and cost-utility analysis of a work-place smoking cessation intervention with and without financial incentives.
    van den Brand FA; Nagelhout GE; Winkens B; Chavannes NH; van Schayck OCP; Evers SMAA
    Addiction; 2020 Mar; 115(3):534-545. PubMed ID: 31849138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial.
    Walker N; Verbiest M; Kurdziel T; Laking G; Laugesen M; Parag V; Bullen C
    BMJ Open; 2019 Feb; 9(2):e023659. PubMed ID: 30808668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
    Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
    Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of use and real-world effectiveness of smoking cessation aids during the COVID-19 pandemic: a representative study of smokers in England.
    Jackson SE; Cox S; Shahab L; Brown J
    Addiction; 2022 Sep; 117(9):2504-2514. PubMed ID: 35491743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.